Загрузка...
Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy
Background: Estimating distant recurrence (DR) risk among women with estrogen receptor–positive (ER+), human epidermal growth factor receptor 2 (HER2)–negative early breast cancer helps decisions on using adjuvant chemotherapy. The 21-gene Oncotype DX recurrence score (RS) is widely used for this. E...
Сохранить в:
| Опубликовано в: : | J Natl Cancer Inst |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5241904/ https://ncbi.nlm.nih.gov/pubmed/27400969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djw149 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|